Patients will not receive direct benefit from taking part in this trial. The main reason for joining is to help researchers learn about treating patients with newly diagnosed AFib. The results may benefit patients in the future.
Patients will not receive direct benefit from taking part in this trial. The main reason for joining is to help researchers learn about treating patients with newly diagnosed AFib. The results may benefit patients in the future.